Loading...
•
Jun 28
Thermo Fisher Q2 2025 Earnings Report
Thermo Fisher Scientific reported its financial results for the second quarter ended June 28, 2025, with revenue growth and increased GAAP diluted EPS, while adjusted EPS saw a slight decrease.
Key Takeaways
Thermo Fisher Scientific delivered a strong second quarter in 2025, with revenue increasing by 3% to $10.85 billion and GAAP diluted EPS growing by 6% to $4.28. The company demonstrated excellent operational performance, driven by its PPI Business System, and continued to advance its growth strategy through innovation and strategic partnerships, despite a slight dip in adjusted EPS.
Second quarter revenue increased by 3% to $10.85 billion, up from $10.54 billion in the prior year.
GAAP diluted EPS grew by 6% to $4.28, compared to $4.04 in the second quarter of 2024.
Adjusted EPS was $5.36, a slight decrease from $5.37 in the same period last year.
The company achieved 2% organic revenue growth, reflecting strong operational execution and market share gains.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
The company will provide updated 2025 financial guidance during its earnings conference call.